Overview
News
Salaries
Products
People
Growth
Offices
Financials

Overview

Ethypharm, a specialty pharma with European roots, focused on the Central Nervous System (CNS) and Critical Care.

News

Press release PRNewswire 2 years ago
Ethypharm announces the appointment of Éric CHEVALIER as Group Human Resources Director
/PRNewswire/ -- Denis DELVAL, President & CEO of the Ethypharm Group, announces the appointment of Éric CHEVALIER as Group Human Resources Director with effect...
Read more
Report
Press release PRNewswire 5 years ago
Ethypharm reinforces its late-stage R&D pipeline with a novel acute treatment of migraine
/PRNewswire/ -- Ethypharm announces today that it has acquired the exclusive rights for the development, registration and commercialization in the top 5...
Read more
Report
Press release PRNewswire 5 years ago
Ethypharm reinforces its late-stage R&D pipeline with a novel acute treatment of migraine
/PRNewswire/ -- Ethypharm announces today that it has acquired the exclusive rights for the development, registration and commercialization in the top 5...
Read more
Report
News YahooFinance 5 years ago
Clever Leaves and Ethypharm Announce German Pharmaceutical Cannabis Partnership
Clever Leaves Partners with Leading European Pharmaceutical Company to Market EU-GMP Certified Medical Cannabis ProductsNEW YORK, March 17, 2021 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (
Read more
Report
Press release PRNewswire 9 years ago
Ethypharm Announces the Appointment of Dan Tovar to the Position of Executive Vice-President Medical Affairs and Drug Development
/PRNewswire/ -- Ethypharm announces the appointment of Dan Tovar to the position of Executive Vice-President Medical Affairs and Drug Development. (Logo:...
Read more
Report
News PE Hub 13 years ago
GE Capital and Ares Management back Ethypharm
Ares Management and GE Capital are mandated lead arrangers for the senior unitranche facilities for Ethypharm, a French portfolio company of Astorg Partners. Proceeds of the facilities will be used to refinance existing indebtedness and fund future acquis
Read more
Report